Author Archive: Jim Lane

rss feed

The Digest’s 2023 Multi-Slide Guide to Chevron

The Digest’s 2023 Multi-Slide Guide to Chevron

March 23, 2023 |

With the acquisition of REG and investments in companies such as Raven SR, Chevron has signaled that, as CEO Mike Wirth put it, “we believe the future of energy to be lower carbon. We intend to be a leader today, and in that future.”  The Chevron team prepared this company investor update for distribution this […]

Read More

The 50 Hottest Companies in the Bioeconomy 2023

The 50 Hottest Companies in the Bioeconomy 2023

March 23, 2023 |

In Washington, the Digest released the rankings for the 50 Hottest Companies in the Bioeconomy. Out of more than 2,000 sector companies, the winners are:

Read More

State of the Bioeconomy 2023

State of the Bioeconomy 2023

March 23, 2023 |

The opening session of ABLC features the State of the Bioeconomy presentation.  Here are the slides from the presentation by Digest editor & publisher Jim Lane on the evening of March 22nd  covering advanced ethanol. renewable diesel, SAF, renewable chemicals, biomaterials, RNG, hydrogen, feedstocks and supply chain,  finance and policy.

Read More

The Digest’s 2023 Multi-Slide Guide to The Andersons

The Digest’s 2023 Multi-Slide Guide to The Andersons

March 22, 2023 |

The company aims to be “ the Most Nimble and Innovative North American Ag Supply Chain Company,” and has operations in the purchase and merchandising of grain, ethanol and plant nutrients (suppling  primary nutrients; strong warehouse and farm center network in Eastern Corn Belt). This up to date presentation covers the newer lines of business […]

Read More

Biden Administration to unveil “bold goals” for biotechnology, biomanufacturing

Biden Administration to unveil “bold goals” for biotechnology, biomanufacturing

March 21, 2023 |

In Washington, the Biden Administration unveiled bold new goals for biotechnology and biomanufacturing, plus a new report — a delegation of 14 high-ranking officials are headed to ABLC 2023 this week in the capital to provide first reactions and briefings to the bioeconomy industry on the new goals and targets of the Administration. Dr. Arati […]

Read More

The Digest’s 2023 Multi-Slide Guide to BASF

The Digest’s 2023 Multi-Slide Guide to BASF

March 21, 2023 |

One of the bioeconomy’s largest public companies has an updated presentation out — all the markets, technologies, sources of revenues, trends, lines of business — launch-stage, growth-stage, maturity and end of life. The BASF team prepared this company investor update for distribution this year.

Read More

The Digest’s 2023 Multi-Slide Guide to Novozymes

The Digest’s 2023 Multi-Slide Guide to Novozymes

March 20, 2023 |

Novozymes – from the last syllable you can guess at their dominance in the world of creating disruptive yields through enzyme innovation — but did you know of their increasingly strong technology in yeast? What next for this company as it diversifies? All the markets, technologies, sources of revenues, trends, lines of business. The Novozymes […]

Read More

Alder SAF100 – Accelerating Development for Next Generation Sustainable Fuels  

Alder SAF100 – Accelerating Development for Next Generation Sustainable Fuels  

March 20, 2023 |

By Derek Vardon,Chief Technology Officer & Bruno Miller, Chief Project Officer, Alder Fuels Special to The Digest Today, we are providing a high-level technical analysis of what we are calling Alder SAF100, a new and 100% sustainable replacement for petroleum-based jet fuel. To demonstrate the viability of reaching that crucial 100% non-fossil production objective, Alder SAF100 […]

Read More

Going for net-zero by 2050 – wishful thinking or realistic goal?  

Going for net-zero by 2050 – wishful thinking or realistic goal?  

March 19, 2023 |

By The Topsoe team Special to The Digest Some would say the goal of reaching net-zero emissions by 2050 is a mega-scale challenge requiring mega-scale solutions. Not to mention a healthy dose of optimism. But this is where ultra-low carbon intensity blue hydrogen comes in and gives hope for transforming even the hardest-to-abate sectors. To […]

Read More

The Digest’s 2023 Multi-Slide Guide to The Andersons

The Digest’s 2023 Multi-Slide Guide to The Andersons

March 16, 2023 |

Twist Bioscience developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a high-throughput silicon platform that allows us to miniaturize the chemistry necessary for DNA synthesis. This translates into time and cost savings for customers across their workflows. Researchers can access quality tools for more accurate NGS, highly customizable Gene Synthesis at scales that fit […]

Read More